semaglutide english Semaglutide, also known as Ozempic, for weight loss - what you need to know Novo Nordisk medicines containing semaglutide
Description
Clinical Trials : Early-phase clinical trials have demonstrated promising results in humans, with significant weight loss and improved glycemic control observed in participants
Common symptoms Bloating related to GLP-1 treatment can present in several ways
The effect of semaglutide in those with obesity and hypertension is as yet undetermined
Give side effects time to improve, as most decrease substantially after 2 to 3 weeks at each dose
